Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.69
Delayed Data
As of Apr 24
 -0.28 / -9.43%
Today’s Change
1.85
Today|||52-Week Range
4.97
+1.51%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 7.75, with a high estimate of 20.00 and a low estimate of 1.00. The median estimate represents a +188.10% increase from the last price of 2.69.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.02%
 
 
 
 
 
 
Growthannually 10.51%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account